Determinants of Change in Prostate-Specific Antigen Over Time and Its Association With Recurrence After External Beam Radiation Therapy for Prostate Cancer in Five Large Cohorts

This publication has 34 references indexed in Scilit:

• Staging for prostate cancer
  Cancer, 2007
• Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
  International Journal of Radiation Oncology*Biology*Physics, 2006
• Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy
  International Journal of Radiation Oncology*Biology*Physics, 2005
• Predictors of Prostate Cancer–Specific Mortality After Radical Prostatectomy or Radiation Therapy
  Journal of Clinical Oncology, 2005
• Individualized Predictions of Disease Progression Following Radiation Therapy for Prostate Cancer
  Journal of Clinical Oncology, 2005
• Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: Findings from a prospective, multi-institutional, phase I/II dose-escalation study
  International Journal of Radiation Oncology*Biology*Physics, 2004
• What to do for prostate cancer patients with a rising PSA?—a survey of Australian practice
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Dose response in prostate cancer with 8–12 years’ follow-up
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Does age influence the behaviour of localized prostate cancer?
  BJU International, 2001
• Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS
  Journal of the American Statistical Association, 1995